GSE210662
ZNF165 as a potential novel immunotherapeutic target for gastric cancer
Background: Cancer testis antigens (CTAs) are an extensive gene family with a unique expression pattern restricted to testis tissues, but aberrantly high expressed in a variety of cancer tissues. In view of this, CTAs are typically considered as efficient biomarkers and targets of immunotherapy. However, limited information is available regarding CTAs as immunotherapeutic targets for gastric cancer (GC) patients. Herein, we evaluated the expression levels of CTAs in both Eastern and Western GC patients and elucidate the expression pattern and functions of a novel CTAs. Overall design: Comparative gene expression profiling analysis of RNA-seq data for MKN28/MKN45 cells with knockdown and overexpressed ZNF165.